CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 956 enrolled
Drug / intervention
Abbott HIV-1/2 VL Point of care Deviceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05048472
NCT05048472N/ACompleted
CompareCT.gov

Implementation of Point of Care HIV Viral Load Monitoring to Improve Viral Load Suppression Among Children, Adolescents and Young People Living With HIV in East Africa

MRC/UVRI and LSHTM Uganda Research Unit·interventional·Posted Sep 17, 2021·Updated Jul 1, 2025

In Brief

A clinical study evaluating Abbott HIV-1/2 VL Point of care Device for HIV and 2 related conditions. Completed, enrolled 956 participants across 7 sites in 4 countries.

Detailed Summary

The purpose of EAPoC-VL project is to examine the feasibility, acceptability, and effectiveness of using point of care viral load (PoC VL) monitoring to improve viral load suppression among children, adolescents and young people (age ≤24 years) living with HIV in Kenya, Rwanda, Tanzania and Uganda.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Viral Load, Point of Care Monitoring
CountriesKenya, Rwanda, Tanzania, Uganda
CollaboratorsKarolinska Institutet, Kilimanjaro Christian Medical Centre, Tanzania, Amsterdam Institute for Global Health and Development, National Institute for Medical Research, Tanzania, Kenya Medical Research Institute, University of Rwanda

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 17, 2021
Enrollment StartAug 19, 2022
Primary CompletionApr 30, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 4.8 years ago

Interventions

Abbott HIV-1/2 VL Point of care Deviceother

Point of care viral load monitoring